VIMAB Group AB (publ)
STO:VIMAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
VIMAB Group AB (publ)
STO:VIMAB
|
SE |
|
Brainstorm Cell Therapeutics Inc
OTC:BCLI
|
US |
|
Amplifon SpA
MIL:AMP
|
IT |
|
Canstar Resources Inc
XTSX:ROX
|
CA |
|
E
|
Entergy Corp
DUS:ETY
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VIMAB's stock price target?
Not Available
VIMAB does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for VIMAB Group AB (publ)?
Projected CAGR
-8%
Over the last 12 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is -8%.
What is the Gross Profit forecast for VIMAB Group AB (publ)?
Projected CAGR
-1%
The compound annual growth rate for Gross Profit over the next 5 years is -1%.